Basal insulin is a vital component in diabetes management, especially for individuals who require consistent blood glucose control. According to the Centers for Disease Control and Prevention’s National Statistics Report, 5.7% of all US adults with diagnosed diabetes (approximately 1.7 million adults aged 20 years or older) use insulin. Furthermore, 12.3% (around 3.6 million adults aged 20 years or older) of these individuals started using insulin within a year of their diagnosis. This highlights the crucial role insulin plays in managing diabetes effectively.
In this article, you will learn about basal insulin, including its types, dosages, benefits, and potential side effects.
Key Takeaways
- Basal insulin maintains stable blood glucose levels all day and night, essential for preventing diabetes complications like cardiovascular disease and neuropathy.
- According to the CDC, 5.7% of US adults with diagnosed diabetes (about 1.7 million) use insulin, highlighting its importance in diabetes management.
- Types of basal insulin include intermediate-acting (NPH), long-acting (glargine and detemir), and ultra-long-acting (degludec), each providing different duration of glucose control.
- Long-acting insulins like glargine (Lantus) and detemir (Levemir) usually need only one daily injection, while NPH may require two injections per day.
- Proper basal insulin dose calculation often starts with 0.4 to 0.5 units per kilogram of body weight per day, adjusted based on individual needs and blood glucose levels.
- Missing basal insulin doses can lead to high blood sugar (hyperglycemia) and long-term complications, while taking too much can cause low blood sugar (hypoglycemia) with symptoms like dizziness and sweating.
What Does Basal Insulin Mean?

Basal insulin is a type of insulin therapy designed to maintain stable blood glucose levels throughout the day and night. Its primary purpose is to provide a constant, low level of insulin that mimics the insulin normally produced by a healthy pancreas. Unlike mealtime insulin, which is taken to manage blood sugar spikes from food intake, basal insulin works in the background to control blood glucose levels during fasting periods and between meals. It is essential for preventing hyperglycemia (high blood sugar) and maintaining overall metabolic stability.
Types of Basal Insulin
Basal insulin medications can be classified into three main types: intermediate-acting, long-acting, and ultra-long-acting insulins.
Intermediate-Acting Insulin (NPH)
Intermediate-acting insulin, such as NPH (Neutral Protamine Hagedorn), is a suspension of human insulin combined with protamine and zinc, which delays its release into the bloodstream. This delay ensures steady insulin levels, typically requiring one or two injections per day for continuous basal coverage. Common brands include Humulin N and Novolin N. These insulins start working within 2 to 4 hours after injection and remain effective for 12 to 18 hours, with peak effectiveness around 4 hours post-injection. Both Humulin N and Novolin N are administered subcutaneously (under the skin).
Long-Acting Insulin
Long-acting insulins, such as glargine and detemir, are designed to be absorbed slowly, providing extended glucose control without significant peaks in insulin levels. Glargine is available under the brand names Lantus, Toujeo, and Basaglar, while detemir is sold as Levemir. These insulins start working between 90 minutes to 4 hours after injection and maintain their effect for up to 24 hours. Due to their steady and prolonged action, they are usually administered once daily. It’s important to note that glargine and detemir should not be mixed with rapid-acting insulins, as this can alter their effectiveness.
Ultra-Long-Acting Insulin
The only ultra-long-acting insulin available is degludec, marketed under the brand name Tresiba. Degludec begins to work within 30 to 90 minutes of injection and remains active in the bloodstream for up to 42 hours, making it the longest-lasting basal insulin. Like long-acting insulins, degludec provides a steady insulin level without peaks, ensuring consistent glucose control. It can also be safely mixed with rapid-acting insulins without compromising its properties.
How Does Basal Insulin Work?
Basal insulin works by mimicking the body’s natural insulin production to maintain stable blood glucose levels. It provides a continuous, low-level supply of insulin that helps to regulate glucose levels between meals and during fasting periods, such as overnight.
When basal insulin is injected, it is absorbed slowly into the bloodstream, ensuring a prolonged and steady release. This slow absorption helps to maintain a consistent insulin level, which is crucial for preventing blood glucose fluctuations.
Basal insulin does not typically have a pronounced peak in its activity, unlike mealtime insulins, which act quickly to manage postprandial (after meal) blood sugar spikes. Instead, basal insulin provides a continuous supply of insulin, mimicking the basal insulin secretion of a healthy pancreas, thus ensuring stable glucose levels around the clock.
Basal Insulin Dose
The general dose of basal insulin varies depending on individual needs and circumstances. Typically, doctors will start patients on a low dose and gradually adjust it based on their blood glucose levels, lifestyle, and how their body responds to the insulin. For many adults, the initial dose may range from 10 to 20 units per day. However, it’s important to remember that insulin requirements can differ significantly between individuals. Factors such as body weight, age, diet, activity level, and other health conditions all play a role in determining the appropriate dose.
How to Calculate Basal Insulin Dose

Calculating the correct basal insulin dose is crucial for effective diabetes management. The process typically starts with determining the total daily insulin requirement, which is often estimated based on the patient’s body weight. For instance, a common basal insulin starting dose is 0.4 to 0.5 units of insulin per kilogram of body weight per day. This total daily dose is then divided between basal and bolus (mealtime) insulin. Typically, basal insulin comprises about 40-50% of the total daily insulin dose. For example, if a patient weighs 70 kilograms, their total daily insulin requirement might be 28 to 35 units. The basal insulin dose would then be approximately 14 to 18 units, administered once or twice daily depending on the type of insulin used.
Example calculations:
For a person weighing 60 kg: Initial dose = 60 kg × 0.2 units/kg = 12 units/day to 60 kg × 0.5 units/kg = 30 units/day.
For a person weighing 80 kg: Initial dose = 80 kg × 0.2 units/kg = 16 units/day to 80 kg × 0.5 units/kg = 40 units/day.
Patients should administer their basal insulin at the same time each day to maintain steady insulin levels. Keeping a detailed log of blood glucose readings, insulin doses, meals, and activities can help identify trends and necessary adjustments. Consult with a doctor regularly to review blood glucose data and adjust doses as needed. Additionally, patients should be educated about the signs of hypo- and hyperglycemia and how to respond appropriately, ensuring they are equipped to manage their insulin therapy effectively.
Benefits of Basal Insulin
The benefits of using basal insulin include maintaining stable blood glucose levels throughout the day and night, which helps prevent long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy. By providing a constant, low level of insulin, basal insulin mimics the body’s natural insulin production, ensuring glucose control during fasting periods and between meals. This steady control can reduce the number of daily injections needed, especially with long-acting and ultra-long-acting formulations, simplifying diabetes management. Consistent use of basal insulin also helps improve overall metabolic stability and enhances the quality of life for individuals with diabetes.
When to Take Basal Insulin

The optimal timing for basal insulin administration depends on the type of insulin used and individual lifestyle factors. Long-acting insulins like glargine (Lantus) and detemir (Levemir) are typically taken once daily, often at the same time each day, to maintain consistent blood glucose levels. Ultra-long-acting insulin, such as degludec (Tresiba), offers more flexibility and can be administered at any time of the day, as long as it’s taken consistently at the same time. Intermediate-acting insulins like NPH may require two injections daily, typically in the morning and evening. Factors such as meal patterns, activity levels, and work schedules can influence the timing of basal insulin doses. To integrate basal insulin into your daily routine, choose a time that fits seamlessly into your schedule, such as first thing in the morning or before bedtime. Setting a daily reminder can help ensure consistency.
Basal Insulin Side Effects

Hypoglycemia, or low blood sugar, is one of the most frequent side effects and can cause symptoms such as dizziness, sweating, confusion, and irritability. Weight gain is another common side effect, often resulting from improved glucose control and increased insulin storage of glucose as fat. Some people may also experience injection site reactions like redness, swelling, or itching.
To manage and mitigate these side effects, it is essential to regularly monitor blood glucose levels and adjust insulin doses as needed in consultation with a doctor. Eating balanced meals and maintaining a consistent eating schedule can help prevent hypoglycemia. Incorporating regular physical activity into your routine can help manage weight gain and improve overall insulin sensitivity. Rotating injection sites can reduce the risk of local skin reactions.
Seek medical advice if you experience severe hypoglycemia that does not respond to treatment, significant or unexplained weight gain, persistent injection site reactions, or any other unusual symptoms. Regular follow-ups with a doctor are important to ensure that your basal insulin regimen is effective and to make any necessary adjustments.
Conclusion
Understanding basal insulin is essential for managing diabetes effectively. By keeping blood glucose levels stable throughout the day and night, basal insulin helps prevent complications and simplifies diabetes management. With different types available, like intermediate-acting, long-acting, and ultra-long-acting insulins, patients can find an option that fits their lifestyle and needs. Monitoring blood glucose levels regularly, adjusting doses as necessary, and being aware of potential side effects is crucial for achieving the best results with basal insulin therapy.
FAQs About Basal Insulin
What is the difference between basal insulin and human insulin?
Basal insulin is designed to provide a constant, low level of insulin to manage blood glucose levels throughout the day and night, mimicking the background insulin produced by the pancreas. Human insulin, on the other hand, is structurally identical to the insulin produced naturally in the human body. Both can be used in diabetes management, but basal insulin specifically targets long-term glucose control.
What is a normal basal insulin level?
A normal basal insulin level varies between individuals but typically aims to keep fasting blood glucose levels within the target range set by diabetes guidelines, often between 80 to 130 mg/dL.
Is basal insulin taken once a day?
Basal insulin can be taken once a day, particularly with long-acting or ultra-long-acting formulations like glargine or degludec. However, some types, such as intermediate-acting insulin (NPH), may require two injections per day for consistent blood glucose control.
Where is the best place to inject basal insulin?
The best places to inject basal insulin are areas with a layer of fat, such as the abdomen, thighs, buttocks, or upper arms. Rotating injection sites within these areas helps prevent skin problems and ensures better absorption.
How do I know if my basal insulin is working?
You can tell if your basal insulin is working by monitoring your fasting blood glucose levels. If your levels remain stable and within the target range overnight and between meals, it indicates that the basal insulin is effectively managing your glucose levels.
Why is basal insulin given at night?
Basal insulin is often given at night to ensure stable blood glucose levels during sleep and to help manage fasting glucose levels in the morning. This timing can help maintain overall glucose control throughout the 24-hour period.
What happens if basal insulin is too high?
If basal insulin is too high, it can lead to hypoglycemia (low blood sugar), which may cause symptoms like dizziness, sweating, confusion, and irritability. Severe hypoglycemia can be dangerous and requires immediate attention.
Does basal insulin need to be refrigerated?
Basal insulin should be refrigerated until it is opened. Once in use, it can typically be kept at room temperature for a specified period, usually around 28 days, depending on the manufacturer’s instructions.
What happens if you don’t take your basal insulin?
If you don’t take your basal insulin, your blood glucose levels can become elevated, leading to hyperglycemia. Over time, this can result in serious complications like cardiovascular disease, neuropathy, and retinopathy.
Can I stop taking insulin if my blood sugar is normal?
No, you should not stop taking insulin if your blood sugar is normal. Consistent insulin use is necessary to maintain those normal levels. Stopping insulin can cause blood glucose levels to rise again. Always follow your prescribed insulin regimen.
Sources
Argano, C., Priola, L., Manno, F., & Corrao, S. (2024). What is the role of basal weekly insulin in clinical practice? The state of the art. Biomedicines, 12(4), 900. https://www.mdpi.com/2227-9059/12/4/900
Nishimura, A., Harashima, S., Fukushige, H., Wang, Y., Liu, Y., Hosoda, K., & Inagaki, N. (2017). A large difference in dose timing of basal insulin introduces risk of hypoglycemia and overweight: A cross-sectional study. Journal of Diabetes Research, 2017, Article 5380500. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380500/




